'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days
3 years, 3 months ago

'Would Lead To A Social Disaster': Centre Appeals Against Kerala HC Decision To Reduce Covishield Dose Interval Of 84 Days

Live Law  

The Centre has preferred an appeal before the Kerala High Court against a Single Bench order allowing the second dose of COVISHIELD to be administered prior to the prescribed interval of 84 days. The appeal has been filed through the Assistant Solicitor General of India P. Vijayakumar.By the aforesaid judgment, the Single bench had directed the appellants to make necessary provisions forthwith. By the aforesaid judgment, the Single bench had directed the appellants to make necessary provisions forthwith in the CoWIN portal so as to enable scheduling of a second dose of COVISHIELD vaccine after four weeks of the first dose being administered for those who were willing to accept the same. "The judgment of the learned single judge would militate against the settled position that in the matters related to Government policy supported by scientific study, the Court shall not meddle with nor substitute its view with the view of the administration," the appeal reads.

Policy Appeal Court Centre Bench Single 84 Days Single Bench Covishield Interval Vaccine Dose  decision  interval  vaccine  dose  disaster  policy  lead  hc  court  order  kerala  days  bench  social  appeal  centre  single  reduce

History of this topic

Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine
1 week, 5 days ago

Supreme Court Says Centre Can Respond To Plea Seeking Direction To Specify Side Effects Of Covishield Vaccine

Live Law  

The Supreme Court on December 10 said the Union Government may file its response to an amendment application seeking that possible adverse effects of Oxford–AstraZeneca's Covishield should be specified in the vaccines including the treatment for those effects. Opposing this, Additional Solicitor General Aishwarya Bhati responded: "Mylords looked into the entire issue of COVID vaccination, which was disposed of by …

Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors
7 months, 2 weeks ago

Covishield vaccine has had more benefits than risks, says study by Kozhikode doctors

The Hindu  

At a time when the safety aspects of the Covishield vaccine have kicked up a row, a retrospective study by two doctors from Kozhikode has claimed that its risks are minimal in view of the benefits. The controversy arose after pharmaceutical company AstraZeneca admitted in the High Court of London, United Kingdom, that its vaccine against COVID-19 had the potential …

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’
7 months, 3 weeks ago

Covishield | Plea in Supreme Court for probe panel for vaccine’s ‘risk factors’

The Hindu  

The controversy over the safety aspects of the Covishield vaccine reached the Supreme Court on Wednesday, May 1, 2024, with a petition seeking the constitution of an expert medical panel to study the risk factors. Now after the document filed in UK court by the developer of Covishield, we are compelled to think on the risk and hazardous consequences of …

Amid Covid surge, Tricity short of vaccine doses
1 year, 8 months ago

Amid Covid surge, Tricity short of vaccine doses

Hindustan Times  

Amid a surge in Covid infections, the Tricity is facing a glaring lack of vaccine availability. Director, health services, Dr Suman Singh has confirmed that the Covid-19 vaccine is currently unavailable, and the department has already communicated this to the Government of India for additional supplies. According to data provided by the health department, a total of 10,89,773 first doses …

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects
1 year, 10 months ago

’Covishield shouldn’t have been rolled out’: Doctor flags ’severe’ side-effects

Live Mint  

A well known British-Indian cardiologist has flagged the cardiovascular side effects of the Covishield vaccine. According to Dr Aseem Malhotra, the vaccine manufactured in India by the Serum Institute is ‘even worse’ than mRNA COVID-19 vaccines when it came to concerns such as heart attacks and strokes. Citing a comparison published in a peer-reviewed journal, he said that the Oxford-AstraZeneca …

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court
1 year, 10 months ago

Not Permissible To Take One Dose Of Covishield And Another Of Covaxin: Centre To Delhi High Court

Live Law  

The Central Government has informed the Delhi High Court that it is not permissible for an individual to take first dose of Covishield and second dose of Covaxin. Central Government’s standing counsel Anurag Ahluwalia told Justice Prathiba M Singh that mixing of two COVID-19 vaccines is not permissible for the first and second dose. The court was hearing a plea …

Corbevax as Covid booster for adults from August 12. Check details
2 years, 4 months ago

Corbevax as Covid booster for adults from August 12. Check details

India Today  

In a boost to India’s fight against coronavirus, the government gave nod to Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Announcing the decision, Union Health minister Mansukh Mandaviya said, “Further Strengthening India's arsenal against Covid-19, Ministry of Health and Family Welfare approves Corbevax as precaution dose for those …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

Deccan Chronicle  

New Delhi: The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield …

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report
2 years, 4 months ago

Corbevax approved as booster for those jabbed with Covishield, Covaxin: Report

Live Mint  

The government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin, news agency PTI has reported on 10 August citing official sources. "Corbevax will be considered as a precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India Today  

The government has approved Biological E's Corbevax as a precautionary dose for those above 18 years fully vaccinated with either Covishield or Covaxin, official sources said on Wednesday. "Corbevax will be considered as a precautionary dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines for …

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients
2 years, 4 months ago

In A First, Biological E's Corbevax Approved As Covid Booster for Covishield, Covaxin Recipients

News 18  

The Centre has approved Biological E’s Corbevax as a Covid-19 precaution dose for those above 18 years fully vaccinated with either Covishield or Covaxin. Union Health Secretary Rajesh Bhushan said, “Corbevax will be available as precaution dose after completion of six months or 26 weeks from the date of administration of the second dose of either Covaxin or Covishield vaccines …

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
2 years, 4 months ago

Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield

India TV News  

Highlights Biological E's Corbevax has been approved as a booster or precaution dose. Covid vaccination: Biological E's Corbevax has been approved as a booster or precaution dose for those above the age of 18, and those who are fully vaccinated with either Covishield or Covaxin. "Corbevax will be considered as a precaution dose after completion of six months or 26 …

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon
2 years, 4 months ago

Govt Nod for Corbevax as Booster for Adults Vaccinated with Covishield, Covaxin Soon

News 18  

The Union health ministry is expected to soon approve Biological E’s Corbevax as a precaution dose for people above 18 years who are double vaccinated with either Covishield or Covaxin, official sources said on Tuesday. “Corbevax will be considered as a precaution dose after completion of 6 months or 26 weeks from the date of administration of the second dose …

Adults may get different vaccine as booster shot instead of Covishield, Covaxin
2 years, 4 months ago

Adults may get different vaccine as booster shot instead of Covishield, Covaxin

Live Mint  

As the government has continued to emphasize Covid booster doses due to the rising number of cases, a panel has recommended a different vaccine for Indian adults. Government panel National Technical Advisory Group on Immunisation has recommended Biological E's Corbevax as a precaution dose for adults fully vaccinated with either Covishield or Covaxin. "Corbevax may be considered for a third/precaution …

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap
2 years, 6 months ago

NTAGI to Review Covaxin, Corbevax Data for 6-12 Yrs Thursday, Discuss Reducing Booster Dose Gap

News 18  

Government advisory panel NTAGI will meet on Thursday to review data on Covaxin and Corbevax vaccines for the 6-12 age group and also deliberate on reducing the gap between the second and precaution doses from the current nine to six months. The agenda for the NTAGI's Standing Technical Sub-Committee meeting includes a discussion on a study by the CMC Vellore …

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report
2 years, 7 months ago

Mix and match of Covid vaccine for booster shots unlikely to be allowed: Report

Live Mint  

The government may not allow the administration of a precaution Covid-19 dose that is different from the one used for primary vaccination, reported news agency PTI, quoting sources, on Thursday. This comes in light of a recent study by the Christian Medical College Vellore, which showed that a booster dose of Covishield after primary vaccination with Covaxin gives 6 to …

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients
2 years, 7 months ago

Biological E seeks EUA of Corbevax as booster for Covishield, Covaxin recipients

Live Mint  

Hyderabad-based Biological E has submitted an application to India's drug regulator, seeking emergency use authorisation for its Covid-19 vaccine Corbevax as a booster dose for adults who have been given two doses of either Covishield or Covaxin, reported news agency PTI, quoting sources. “We are now submitting the marketing authorization application for grant of permission Corbevax for restricted use in …

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad
2 years, 7 months ago

India Likely to Reduce Gap Between 2nd Covid Vaccine Shot, Booster Dose for Those Flying Abroad

News 18  

India may reduce the gap between the second Covid-19 vaccine shot and the precautionary third dose from nine to six months for citizens who are scheduled to travel abroad, especially to countries that have made it compulsory for travelers to produce their booster certificates. According to the advisory issued by the Union Ministry of Health and Family Welfare, the gap …

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court
2 years, 7 months ago

No Haste In Granting Emergency Use Authorization To Covaxin & Covishield: Supreme Court

Live Law  

In its judgment holding that the policy of the Union Government on COVID-19 vaccination policy is reasonable, the Supreme Court rejected the contention that restricted emergency use approvals had been granted to COVISHIELD and COVAXIN in haste, without thorough review of the relevant data.The court observed that the challenge to the procedures adopted by the expertbodies while granting. "However, it …

19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre's Response On Parents' Plea
2 years, 8 months ago

19 Year Old Allegedly Dies Post Covishield Vaccination: Kerala High Court Seeks Centre's Response On Parents' Plea

Live Law  

The parents of a 19-year-old student have moved the Kerala High Court seeking justice alleging that their daughter died due to the compulsory administration of the Covishield vaccine and they have sought Rs 1 crore as compensation for the death of their only daughter.Justice N Nagaresh has sought the view of the central government on the petition.The petitioners' daughter, a …

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference
2 years, 8 months ago

Serum Institute to Give Free Covishield Vials to Private Vaccination Centres to Compensate for Price Difference

News 18  

A day after slashing the price of the precaution dose of Covishield to Rs 225 per shot for private hospitals, the Serum Institute of India told the Centre on Sunday that it will compensate for the price difference for the unexpired stocks lying with private centres in the form of free vials of fresh stocks, official sources said. Vaccine majors …

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield
2 years, 9 months ago

Why India's vaccine advisory body recommends reducing second-dose gap for Covishield

Firstpost  

The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to eight to 16 weeks, from the current gap of 12 to 16 The National Technical Advisory Group on Immunisation has recommended that the gap between the first and second dose of Covishield should be reduced to …

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet
2 years, 9 months ago

2nd Covishield Dose Can Now Be Taken Between 8-16 Weeks After 1st Dose, No Word on Covaxin Yet

News 18  

The National Technical Advisory Group on Immunisation has recommended administering the second dose of Covid-19 vaccine Covishield between eight and 16 weeks after the first dose, officials said on Sunday. Under the National Covid-19 Vaccination Strategy, the second dose of Covishield is to be given between 12-16 weeks after the first dose. An official source said the latest recommendation of …

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16
2 years, 9 months ago

Covishield 2nd dose can be given between 8-16 weeks after 1st, instead of 12-16

India TV News  

Highlights NTAGI recommended administering 2nd dose of Covishield between 8-16 weeks after the first dose. Presently, the second dose of Covishield is given between 12-16 weeks after the first dose. India's apex body on immunisation NTAGI has recommended administering the second dose of COVID-19 vaccine Covishield between eight and 16 weeks after the first dose, official sources said on Sunday …

AP targets first dose of CorBevax for 14.9 lakh children
2 years, 9 months ago

AP targets first dose of CorBevax for 14.9 lakh children

Deccan Chronicle  

Vijayawada: The Andhra Pradesh government aims to administer the Covid-19 vaccine, called CorBevax, to 14.90 lakh children aged between 12 and 14 years by taking up a special campaign in schools from March 21. Though state health authorities started administering the Covid jab to the targeted children at Covid Vaccination Centres from March 16 in the state, they will be …

Decision on mixing and matching of booster dose of Covid vaccines will be based on science: Govt
2 years, 9 months ago

Decision on mixing and matching of booster dose of Covid vaccines will be based on science: Govt

India Today  

The government on Thursday said that any decision on the mixing and matching of booster dose of COVID-19 vaccines will be taken based on science. Addressing a press conference here, NITI Aayog Member V K Paul said studies are going on regarding the mixing and matching of booster doses of Covid-19 vaccines and they are being "constantly reviewed". READ | …

Approach High Courts Against Vaccine Mandates Of States : Supreme Court Suggests To Petitioner
2 years, 10 months ago

Approach High Courts Against Vaccine Mandates Of States : Supreme Court Suggests To Petitioner

Live Law  

On Monday, the Supreme Court expressed concern that it might not be able to decide specific cases of vaccine mandates imposed by the State Governments and other authorities and the same can be taken up by the respective High Courts. Later, the Petitioner, Dr. Jacob Puliyel, had filed an application assailing specific vaccine mandates imposed by State Governments of Madhya …

How conditional market authorisation to Covishield and Covaxin will change India’s COVID-19 vaccine drive
2 years, 10 months ago

How conditional market authorisation to Covishield and Covaxin will change India’s COVID-19 vaccine drive

Firstpost  

Highly-placed sources have said that the conditional market authorisation will now allow the two vaccines to be made available at private hospitals and clinics at pre-decided costs India’s COVID-19 vaccination drive is about to witness a change after the drug regulator on Thursday granted a conditional market authorisation for Covishield and Covaxin, the two coronavirus vaccines widely used in the …

Booster Vaccine Shots For All: Bombay High Court Seeks Response From Centre & State
2 years, 11 months ago

Booster Vaccine Shots For All: Bombay High Court Seeks Response From Centre & State

Live Law  

The Bombay High Court on Friday sought responses to a PIL seeking directions to frame and implement a policy for administering the booster vaccine shot against the Covid-19 virus. During Friday's hearing, Kapadia expressed concern regarding the ambiguity around booster vaccine shots. The plea filed by Kapadia and lawyer Kunal Tiwari has sought framing and swift implementation of vaccine-booster policy …

Explained | Does data support booster dose of same vaccine?
2 years, 11 months ago

Explained | Does data support booster dose of same vaccine?

The Hindu  

The story so far: On January 5, five days before the rollout of the ‘precaution dose’, scientifically called a third or booster dose, for people older than 60 years with comorbidities, health-care and frontline workers, the Government announced that all eligible individuals will receive a homologous — the same vaccine as used in the primary vaccination— vaccine as the third …

Expert Advice Based On Scientific Study Cannot Be Substituted By A Judgment Of Constitutional Courts: Kerala HC While Upholding 84 Days Dose Interval For Covishield
3 years ago

Expert Advice Based On Scientific Study Cannot Be Substituted By A Judgment Of Constitutional Courts: Kerala HC While Upholding 84 Days Dose Interval For Covishield

Live Law  

Reversing a Single Judge decision, the Kerala High Court on Friday delivered a significant decision ruling that the second dose of the COVISHIELD vaccine can only be administered after the prescribed dose interval of 84 days. In its 94-paged judgment, a Division Bench of Chief Justice S Manikumar and Justice Shaji P Chaly has elaborated on why the decision of …

Kerala High Court Allows Centre's Appeal Against Single Judge Decision To Reduce Covishield Dose Interval
3 years ago

Kerala High Court Allows Centre's Appeal Against Single Judge Decision To Reduce Covishield Dose Interval

Live Law  

In a significant judgment, the Kerala High Court on Friday has allowed the appeal preferred by the Central Government against the Single Judge decision allowing the second dose of COVISHIELD to be administered prior to the prescribed interval of 84 days.A Division Bench of Chief Justice S Manikumar and Justice Shaji P Chaly was hearing an appeal preferred by the …

'A Citizen Suffering Due To State-Sponsored Vaccination Scheme': Kerala HC Orders Expeditious Redressal Of Plea Seeking Booster Shot For Intl Travel
3 years, 1 month ago

'A Citizen Suffering Due To State-Sponsored Vaccination Scheme': Kerala HC Orders Expeditious Redressal Of Plea Seeking Booster Shot For Intl Travel

Live Law  

The Kerala High Court on Tuesday directed the Centre to expeditiously redress the grievance of a petitioner seeking administration of the third dose of an internationally recognized Covid-19 vaccine for NRIs, who had already received two doses of Covaxin, which is not globally recognized for international travel.Justice P.V. The Kerala High Court on Tuesday directed the Centre to expeditiously redress …

Centre's vaccination scheme has created 2 classes of citizens in India: Kerala HC
3 years, 1 month ago

Centre's vaccination scheme has created 2 classes of citizens in India: Kerala HC

Deccan Chronicle  

Kochi: The Centre's vaccination scheme has created two classes of citizens in India - those who got COVAXIN, whose movements are restricted, and those who received COVISHIELD and can go anywhere -- Kerala High Court said on Tuesday. The observation by Justice P V Kunhikrishnan came during the hearing of a man's plea for a third jab of an internationally …

'Let's Wait For WHO Decision On COVAXIN' : Supreme Court Adjourns Plea For Re-Vaccination Option
3 years, 1 month ago

'Let's Wait For WHO Decision On COVAXIN' : Supreme Court Adjourns Plea For Re-Vaccination Option

Live Law  

The Supreme Court on Friday posted for after the Diwali vacation a PIL seeking that in view of COVAXIN not having received WHO approval, individuals who have received COVAXIN shots to be re-vaccinated with COVISHIELD. The petition prays for directions to the UOI, Directorate General of Health Services, ICMR and Bharat Biotech to 'not restrain those who voluntarily, at their …

Cannot play with lives of people: SC on plea seeking revaccination with Covishield
3 years, 1 month ago

Cannot play with lives of people: SC on plea seeking revaccination with Covishield

India Today  

The Supreme Court on Friday said that it cannot play with the lives of people by directing the Centre to revaccinate people with Covishield who are fully vaccinated with Covaxin to enable them to travel abroad during the Covid-19 pandemic. The apex court was hearing a petition that said that Covaxin was not approved by the World Health Organisation and …

Second dose of Covid vaccine overdue for over 11 crore people: Govt data
3 years, 1 month ago

Second dose of Covid vaccine overdue for over 11 crore people: Govt data

Live Mint  

Over 11 crore people who have taken the first shot of COVID-19 vaccine have not got themselves jabbed with the second dose even after the expiry of the prescribed interval between two doses, according to government data. The data showed that over 3.92 crore beneficiaries are more than six weeks overdue for their second dose, around 1.57 crore are up …

11 crore people skipped second dose of Covid-19 vaccine, shows govt data
3 years, 1 month ago

11 crore people skipped second dose of Covid-19 vaccine, shows govt data

India Today  

Over 11 crore people who have taken the first shot of Covid-19 vaccine have not got themselves jabbed with the second dose even after the expiry of the prescribed interval between two doses, according to government data. The data showed that over 3.92 crore beneficiaries are more than six weeks overdue for their second dose, around 1.57 crore are up …

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax
3 years, 2 months ago

Biological E seeks DCGI’s nod for phase-3 trial of Corbevax as booster dose in those vaccinated with Covishield or Covax

Live Mint  

Hyderabad-based pharmaceutical company Biological E has sought permission from India's drug regulator to conduct the phase-3 clinical trial for its COVID-19 vaccine Corbevax as a single booster dose for those who have been fully vaccinated with Covishield or Covaxin. The company, meanwhile, has put in an application seeking the nod of the Drugs Controller General of India to conduct the …

Incorrect Date & Venue On COVID Vaccination Certificate: Kerala High Court Directs Centre, State To Rectify Error Within 3 Weeks
3 years, 2 months ago

Incorrect Date & Venue On COVID Vaccination Certificate: Kerala High Court Directs Centre, State To Rectify Error Within 3 Weeks

Live Law  

The Kerala High Court on Tuesday directed the Central government and the State to issue a corrected vaccination certificate within three weeks to the petitioner, thereby removing the discrepancy in date and venue printed on his vaccination certificate. The District Medical Officer submitted an enquiry report before the Court admitting that a mistake had been made on the vaccination certificate …

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19
3 years, 2 months ago

Centre received 65.25 crore Covishield doses, 9.1 crore Covaxin doses till September 19

India Today  

According to official documents, the Government of India received over 65.25 crore Covishield doses from Serum Institute of India and 9.1 crore doses of Covaxin from Bharat Biotech till September 19. Pune-based Serum Institute supplied 20.29 lakh doses of Covishield to the Union Ministry of Health in September as committed by Prakash Kumar Singh, the company's director of government and …

COVID- Cancer Patient Approaches Delhi High Court Allowing Him To Take Covaxin As Second Dose Instead Of Covishield, Notice Issued
3 years, 2 months ago

COVID- Cancer Patient Approaches Delhi High Court Allowing Him To Take Covaxin As Second Dose Instead Of Covishield, Notice Issued

Live Law  

The Delhi High Court has issued notice on the petition filed by a cancer patient seeking permission to take Covaxin as the second dose for vaccination instead of Covishield, which was administered to him as the first dose. Moved by one Madhur Mittal through Advocate Sanjay S Chhabra, the petition states that in March this year, he had got his …

COVID Vaccination- Kerala High Court Declines To Grant Interim Stay On Single Judge Decision Allowing Early Administration Of Second Jab
3 years, 2 months ago

COVID Vaccination- Kerala High Court Declines To Grant Interim Stay On Single Judge Decision Allowing Early Administration Of Second Jab

Live Law  

The Kerala High Court on Monday declined to stay the single judge decision allowing early administration of the second dose of COVISHIELD vaccine to the workers of two petitioner companies before completion of the prescribed 84 day-gap.A Division Bench of Chief Justice S Manikumar and Justice Shaji P Chaly was hearing an appeal preferred by the Central government alleging that …

Incorrect Date And Venue On Vaccination Certificate: Kerala High Court Directs Enquiry To Verify If Its A Genuine Mistake Or Mischief
3 years, 3 months ago

Incorrect Date And Venue On Vaccination Certificate: Kerala High Court Directs Enquiry To Verify If Its A Genuine Mistake Or Mischief

Live Law  

The Kerala High Court on Thursday directed an enquiry into a matter where incorrect date and venue were displayed on the petitioner's Covid-19 vaccination certificate for his second dose, to verify if it was a genuine mistake or some mischief.Justice P V Kunhikrishnan remarked that if the incorrect details on the certificate were found to be a result of any …

Covid-19: India likely to allow a smaller gap between two doses of Covishield
3 years, 3 months ago

Covid-19: India likely to allow a smaller gap between two doses of Covishield

Live Mint  

NEW DELHI: India is likely to allow a smaller gap between AstraZeneca COVID-19 vaccine doses for inoculations being carried out privately, in line with a court order, two sources told Reuters. Private hospitals and clinics will give their paying patients the option to receive their second dose of the vaccine four weeks after the first, down from between 12 and …

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October
3 years, 3 months ago

Serum Institute of India to supply nearly 22 cr doses of Covishield to Centre in October

India Today  

The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the 'Vaccine Maitri' programme, official sources said. In a communication to the Centre on Monday, Prakash Kumar Singh, …

The lag between jabs: The Hindu Editorial on the gap between two Covishield doses
3 years, 3 months ago

The lag between jabs: The Hindu Editorial on the gap between two Covishield doses

The Hindu  

The Kerala High Court’s intervention regarding the time lag between the two doses of Covishield vaccine is both interesting and unusual. The direction that CoWIN, the national vaccination portal, should allow scheduling of the second dose after 28 days — the period initially fixed — for those who want early protection is likely to be questioned on appeal, even though …

Allow Covishield second dose four weeks after first, says Kerala HC
3 years, 3 months ago

Allow Covishield second dose four weeks after first, says Kerala HC

The Hindu  

The Kerala High Court on Monday directed the Central government to make necessary provisions forthwith in the CoWIN portal to enable those who want to take the second dose of Covishield vaccine after four weeks in terms of the initial protocol, to schedule the second dose of Covishield in the portal. Suresh Kumar issued the directive while allowing a writ …

Kerala High Court directs Centre to allow Covishield second dose four weeks after first jab
3 years, 3 months ago

Kerala High Court directs Centre to allow Covishield second dose four weeks after first jab

Firstpost  

The High Court said that even according to the Union Health Ministry’s policy, the people shall have the choice to get early vaccination. Kochi: The Kerala High Court has directed the Centre to allow scheduling, on CoWIN portal, of second COVISHIELD dose after four weeks from the first for those who want to take it earlier than the present suggested …

Discover Related